POINT-OF-CARE ASSESSMENT OF NOAC-INDUCED ANTICOAGULATION: THE NOVEL HAEMONETICS TEG 6S SYSTEM

New oral anticoagulants (NOACs) including direct thrombin inhibitors (DTIs) and Xa inhibitors offer major advantages over vitamin K antagonists. Although officially these agents do not require monitoring, bleeding and ischemic events occur raising concerns for over or under inhibition during NOAC